Kezar Life Sciences, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for KZR, updated each market day.
KZR AI Sentiment
AI sees no strong directional signal for Kezar Life Sciences, Inc. Common Stock stock over the next 10 market days.
Prediction date: July 13, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Kezar Life Sciences, Inc. Common Stock
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Sector
Exchange
Market Cap
$54,373,479
Cap Tier
Employees
9
Headquarters
SOUTH SAN FRANCISCO, CA
Listed Since
June 21, 2018
KZR Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
KZR Volatility
Kezar Life Sciences, Inc. Common Stock has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
